Short Bowel Syndrome Infographics
Short Bowel Syndrome Market

Short Bowel Syndrome (SBS) is a congenital or acquired condition affecting the small intestine, hallmarked by loss of intestinal absorptive capacity with resultant malabsorption, dehydration, and malnutrition. Several Short Bowel Syndrome symptoms include diarrhea, greasy, foul-smelling stools, fatigue, weight loss, malnutrition, and swelling (edema) in the lower extremities


Some of Short Bowel Syndrome Facts:

  • Short Bowel Syndrome is considered a rare disease.
  • Short Bowel Syndrome affects about three out of every million people in the world.
  • Approximately 10,000 - 20,000 people suffer from Short Bowel Syndrome in the United States.
  • Women are more likely to suffer from Short Bowel Syndrome as compared to men.


Short Bowel Syndrome Epidemiology Segmentation

  • Short Bowel Syndrome Prevalent Cases
  • Prevalent Cases of Short Bowel Syndrome-Intestinal Failure
  • Age-specific Short Bowel Syndrome Cases
  • Gender-specific Short Bowel Syndrome Cases
  • Etiology-specific Short Bowel Syndrome Cases


Short Bowel Syndrome Epidemiological Insights Observed in 2020

  • The total Short Bowel Syndrome incident cases in the 7MM were observed to be 34,713.
  • In 2020, the United States had the largest incident population of Short Bowel Syndrome in the 7MM countries.
  • Among the EU5 countries, France was found to have the highest Short Bowel Syndrome incident cases whereas Spain had the lowest incident cases in 2020.


Short Bowel Syndrome Market Insight

The Short Bowel Syndrome market is expected to grow at a CAGR of 5.82% during the study period [2018-2030] in the 7MM. 


Short Bowel Syndrome Market Drivers

  • Increasing research and development
  • Emerging pipeline
  • Glp-2 drugs
  • Rising awareness


Short Bowel Syndrome Market Barriers

  • Side effects of some therapies
  • Patients are at high risk
  • Misdiagnosis of disease


Short Bowel Syndrome Emerging Drugs

The emerging drugs of the Short Bowel Syndrome market are

  • Glepaglutide
  • Apraglutide
  • NM 002, and several others


Short Bowel Syndrome Companies 

The key players working in the Short Bowel Syndrome market are

  • Zealand Pharma
  • VectivBio AG
  • 9 Meters Biopharma, and several others